Skip to main content
SpringerLink
Log in

Control of enterohaemorrhagicEscherichia coli infection: The need for a network involving microbiological laboratories and clinical and public health institutions

  • Editorial
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML: Hemorrhagic colitis associated with a rareEscherichia coli serotype. New England Journal of Medicine 1983, 308: 681–685.

    PubMed  Google Scholar 

  2. Bell BR, Goldoft M, Griffin PM: A multistate outbreak ofEscherichia coli O157:H7-associated bloody diarrhea and hemolytic-uremic syndrome from hamburgers: the Washington experience. Journal of the American Medical Association 1994, 272: 1349–1353.

    PubMed  Google Scholar 

  3. Burnens AP Boss P, Orskov F, Orskov I, Schaad UB, Muller F, Heinzle R, Nicolet J: Occurrence and phenotypic properties of verotoxin producingEscherichia coli in sporadic cases of gastroenteritis. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 631–634.

    Google Scholar 

  4. Cameron AS, Beers MY, Walker CC: Community outbreak of hemolytic uremic syndrome attributable toEscherichia coli O111:NM — South Australia, 1995. Morbidity and Mortality Weekly Report 1995, 44: 550–558.

    PubMed  Google Scholar 

  5. Caprioli A, Luzzi I, Rosmini F, Resti C, Edefonti A, Perfumo F, Farina C, Goglio A, Gianviti A, Rizzoni G: Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producingEscherichia coli. Journal of Infectious Diseases 1994, 169:208–211.

    PubMed  Google Scholar 

  6. Pierard D, Van Etterijck R, Breynaert J, Moriau L, Lauwers S: Results of screening for verocytotoxin-producingEscherichia coli in faeces in Belgium. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 198–201.

    Google Scholar 

  7. Ricotti GC, Buonomini MI, Merlitti A, Karch H, Luzzi I, Caprioli A: A fatal case of hemorrhagic colitis, thrombocytopenia, and renal failure associated with verotoxin-producing, non-O157Escherichia coli. Clinical Infectious Diseases 1994, 19: 815–816.

    PubMed  Google Scholar 

  8. Reida P, Wolff M, Pohls H-W, Kuhlmann W, Lehmacher A, Aleksic S, Karch H, Bockemühl J: An outbreak due to entero-haemorrhagicEscherichia coli O157:H7 in a children's day care centre characterized by person-to-person transmission and environmental contamination. Zentralblatt für Bakteriologie 1994, 281: 534–543.

    Google Scholar 

  9. Mariani Kurkdjian P, Denamur E, Milon A, Picard B, Cave H, Lambert Zechovsky N, Loirat C, Goullet P, Sansonetti PJ, Elion J: Identification of a clone ofEscherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France. Journal of Clinical Microbiology 1993, 31:296–301.

    PubMed  Google Scholar 

  10. Tarr PI:Escherichia coli O157:H7: Clinical, diagnostic and epidemiological aspects of human infection. Clinical Infectious Diseases 1995, 20: 1–10.

    PubMed  Google Scholar 

  11. Boyce TG, Swerdlow DL, Griffin PM:Escherichia coli O157:H7 and the hemolytic uremic syndrome. New England Journal of Medicine 1995, 333: 364–368.

    PubMed  Google Scholar 

  12. Carter AO, Borczyk AA, Carlson JA, Harvey B, Hockin JC, Karmali MA, Krishnan C, Korn DA, Lior H: A severe outbreak ofEscherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. New England Journal of Medicine 1987, 317: 1496–1500.

    PubMed  Google Scholar 

  13. Lingwood CA: Verotoxins and their glycolipid receptors. Advances in Lipid Research 1993, 25: 189–211.

    PubMed  Google Scholar 

  14. Ludwig K, Ruder H, Rott HD, Karch H: Outcome of an enterohaemorrhagicEscherichia coli O157 infection in monozygotic twins. Lancet 1996, 347: 196–197.

    Google Scholar 

  15. Remuzzi G, Ruggenenti P: The hemolytic uremic syndrome. Kidney International 1995, 47: 2–19.

    Google Scholar 

  16. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. New England Journal of Medicine 1991, 325: 393–397.

    PubMed  Google Scholar 

  17. Siegler RL, Edwin SS, Christofferson RD, Mitchell MD: Endothelin in the urine of children with the hemolytic uremic syndrome. Pediatrics 1991, 88: 1063–1066.

    PubMed  Google Scholar 

  18. Benigni A, Boccardo P, Noris M, Remuzzi G, Siegler RL: Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome. Lancet 1992, 339: 835–836.

    PubMed  Google Scholar 

  19. Tönshoff B, Momper R, Kühl PG, Schweer H, Schärer K, Seyberth HW: Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney International 1990, 37: 1134–1141.

    PubMed  Google Scholar 

  20. Obrig TG, Del Vecchio PJ, Brown JE, Moran TR Rowland BM, Judge TK: Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infection and Immunity 1988, 56: 2373–2378.

    PubMed  Google Scholar 

  21. Tesh VL, Ramegowda B, Samuel JE: Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infection and Immunity 1994, 62: 5085–5094.

    PubMed  Google Scholar 

  22. Cohen A, Madrid Marina V, Estrov Z, Freedman MH, Lingwood CA, Dosch HM: Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. International Immunology 1990, 2: 1–8.

    PubMed  Google Scholar 

  23. Siegler RL, Milligan MK, Burningham TH, Christofferson RD, Chang SY, Jorde LB: Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. Journal of Pediatrics 1991, 118: 195–200.

    PubMed  Google Scholar 

  24. Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L: Randomized, controlled trial of antibiotic therapy forEscherichia coli O157:H7 enteritis. Journal of Pediatrics 1992, 121: 299–303.

    PubMed  Google Scholar 

  25. Ostroff SM, Kobayashi JM, Lewis JH: Infections withEscherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. Journal of the American Medical Association 1989, 262: 355–359.

    PubMed  Google Scholar 

  26. Pavia AT, Nichols CR, Green DP Tauxe RV, Mottice S, Greene KD, Wells JG, Siegler RL, Brewer ED, Hannon D, et al.: Hemolytic-uremic syndrome during an outbreak ofEscherichia coli O157:1-17 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. Journal of Pediatrics 1990, 116: 544–551.

    PubMed  Google Scholar 

  27. Armstrong GD, Rowe PC, Goodyer P, Orrbine E, Klassen TP, Wells G, MacKenzie A, Lior H, Blanchard C, Auclair F, Thompson B, Rafter DJ, McLaine PN: A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. Journal of Infectious Diseases 1995, 171: 1042–1045.

    PubMed  Google Scholar 

  28. Maloney MD, Lingwood CA: CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagicEscherichia coli pathogenesis. Journal of Experimental Medicine 1994, 180: 191–201.

    PubMed  Google Scholar 

  29. Gunzer F, Karch H: Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology. Journal of Clinical Microbiology 1993, 31: 2604–2610.

    PubMed  Google Scholar 

  30. Karch H, Wiss R, Gloning H, Emmrich P, Aleksic S, Bockemühl J: [Hemolytic-uremic syndrome in infants due to verotoxin-producingEscherichia coli]. Deutsche Medizinische Wochenschrift 1990, 115: 489–495.

    PubMed  Google Scholar 

  31. Bitzan M, Ludwig K, Klemt M, König H, Büren J, Müller-Wiefel DE: The role ofEscherichia coli O157 infections in the classical (enteropathic) haemolytic uraemic syndrome: Results of a Central European, multicentre study. Epidemiology and Infection 1993, 110: 183–196.

    PubMed  Google Scholar 

  32. Wright DJ, Chapman PA, Siddons CA: Immunomagnetic separation as a sensitive method for isolatingEscherichia coli O157 from food samples. Epidemiology and Infection 1994, 113: 31–39.

    PubMed  Google Scholar 

  33. Chapman PA, Wright DJ, Siddons CA: A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producingEscherichia coli O157 from bovine faeces. Journal of Medical Microbiology 1994, 40: 424–427.

    PubMed  Google Scholar 

  34. Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM: Serological identification ofEscherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 1991, 337: 138–140.

    PubMed  Google Scholar 

  35. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL: Transmission ofEscherichia coli O157:H7 infection in Minnesota child day-care facilities. Journal of the American Medical Association 1993, 269: 883–888.

    PubMed  Google Scholar 

  36. Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN: A prospective study of exposure to verotoxin-producingEscherichia coli among Canadian children with haemolytic uraemic syndrome. Epidemiology and Infection 1993, 110: 1–7.

    PubMed  Google Scholar 

  37. Willshaw GA, Thirlwell J, Jones AP, Parry S, Salmon RL, Hickey M: Verocytotoxin-producingEscherichia coli O157 in beefburgers linked to an outbreak of diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome in Britain. Letters in Applied Microbiology 1994, 19: 304–307.

    PubMed  Google Scholar 

  38. Karch H, Rüssmann H, Schmidt H, Schwarzkopf A, Heesemann J: Long-term shedding and clonal turnover of enterohemorrhagicEscherichia coli O157 in diarrhoeal diseases. Journal of Clinical Microbiology 1995, 33: 1602–1605.

    PubMed  Google Scholar 

  39. Centers for Disease Control:Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami — Washington and California, 1994. Morbidity and Mortality Weekly Report 1995, 44: 157–160.

    Google Scholar 

  40. Feng P:Escherichia coli serotype O157:H7: novel vehicles of infection and emergence of phenotypic variants. Emerging Infectious Diseases 1995, 1: 47–52.

    PubMed  Google Scholar 

  41. Swerdlow DL, Woodruff BA, Brady RC, Griffin PM, Tippen S, Donnell HDJ, Geldreich E, Payne BJ, Meyer AJ, Wells JG, et al.: A waterborne outbreak in Missouri ofEscherichia coli O157:H7 associated with bloody diarrhea and death. Annals of Internal Medicine 1992, 117:812–819.

    PubMed  Google Scholar 

  42. Keene WE, McAnulty JM, Hoesly FC, Williams P, Hedberg K, Oxman GL, Barrett TJ, Pfaller MA, Fleming DW: A swimming-associated outbreak of hemorrhagic colitis caused byEscherichia coli O157:H7 and Shigella sonnei. New England Journal of Medicine 1994, 331: 579–584.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Hygiene und Mikrobiologie, Universität Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany

    H. Karch

Authors
  1. H. Karch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karch, H. Control of enterohaemorrhagicEscherichia coli infection: The need for a network involving microbiological laboratories and clinical and public health institutions. Eur. J. Clin. Microbiol. Infect. Dis. 15, 276–280 (1996). https://doi.org/10.1007/BF01695657

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695657

Search

Navigation